Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Managing endothelial dysfunction in COVID‐19 with statins, beta blockers, nicorandil, and oral supplements: A pilot, double‐blind, placebo‐controlled, randomized clinical trial
Kamal Matli, Abdulrahman Al Kotob, Wassim Jamaleddine, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 10, pp. 2323-2330
Open Access | Times Cited: 12

Showing 12 citing articles:

Statins in hospitalized COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
Yajuan Ren, Guizuo Wang, Dong Han
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 15
Vascular manifestations of COVID-19: Endothelial dysfunction and damage
Paula Poyatos, Miquel Gratacós, Sana Ayyoub, et al.
Elsevier eBooks (2025), pp. 323-334
Closed Access
Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review
Carles Vilaplana-Carnerero, Maria Giner‐Soriano, Ángela Domı́nguez, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1206-1206
Open Access | Times Cited: 14
Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients admitted to hospital
Fumiki Yoshihara, Yasushi Matsuzawa, Kiyomasa Nakatsuka, et al.
Hypertension Research (2024) Vol. 47, Iss. 7, pp. 1943-1951
Closed Access | Times Cited: 3
Prior Statin vs In-Hospital Statin Usage in Severe COVID-19: Review and Meta-Analysis
Iad Alhallak, Hakan Paydak, Jawahar L. Mehta
Current Problems in Cardiology (2023) Vol. 48, Iss. 9, pp. 101810-101810
Open Access | Times Cited: 6
Treating COVID-19: Targeting the Host Response, Not the Virus
David S. Fedson
Life (2023) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 4
RAAS-Hemmung und darüber hinaus – Herz-Kreislauf-Medikation bei Patienten mit einem Risiko für oder Erkrankung durch COVID-19
Alexander Dutsch, Heribert Schunkert
Herz (2023) Vol. 48, Iss. 3, pp. 206-211
Open Access | Times Cited: 4
Latest development of approved COVID-19 drugs and COVID-19 drugs undergoing late stage clinical trials
Bingru Feng, Kai Fu
Frontiers in Drug Discovery (2023) Vol. 3
Open Access | Times Cited: 3
Statins - From Lipid-Lowering Benefits to Pleiotropic Effects

IntechOpen eBooks (2023)
Open Access | Times Cited: 2
Does the Number of Publications Matter for Academic Promotion in Higher Education? Evidence from Lebanon
Pierre Boutros, Ali Fakih, Sara Kassab, et al.
Social Sciences (2022) Vol. 11, Iss. 10, pp. 454-454
Open Access | Times Cited: 4
Association of antihypertensive drugs with COVID-19 outcomes: a drug-target Mendelian randomization study
Kun Zhang, Hengxing Gao, Mingwei Chen
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1
A Review of Statins and COVID-19
Justin H. Shiu, Heather N. Pham, Navneet Singh, et al.
IntechOpen eBooks (2023)
Open Access
Page 1

Scroll to top